Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/99774COMPARTIR / EXPORTAR:
 SHARE
 CORE
BASE
|
|
| Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
| Título: | Targeted delivery of pharmacological chaperones for Gaucher disease to macrophages by a mannosylated cyclodextrin carrier |
Autor: | Rodríguez-Lavado, Julio; Mata, Mario de la CSIC ORCID; Jiménez Blanco, José L.; García Moreno, María Isabel; Benito, Juan M. CSIC ORCID CVN ; Díaz-Quintana, Antonio; Sánchez-Alcázar, José Antonio CSIC ORCID ; Ortiz-Mellet, Carmen; García Fernández, José Manuel CSIC ORCID | Fecha de publicación: | 2014 | Editor: | Royal Society of Chemistry (UK) | Citación: | Organic and Biomolecular Chemistry 12(14): 2289-2301 (2014) | Resumen: | Gaucher disease (GD) is a rare monogenetic disorder leading to dysfunction of acid β-glucosidase (β-glucocerebrosidase; GCase) and accumulation of glucosylceramide in lysosomes, especially in macrophages (Gaucher cells). Many of the mutations at the origin of GD do not impair the catalytic activity of GCase, but cause misfolding and subsequent degradation by the quality control system at the endoplasmic reticulum. Pharmacological chaperones (PCs) capable of restoring the correct folding and trafficking of the endogenous mutant enzyme represent promising alternatives to the currently available enzyme replacement and substrate reduction therapies (ERT and SRT, respectively), but unfavorable biodistribution and potential side-effects remain important issues. We have now designed a strategy to enhance the controlled delivery of PCs to macrophages that exploit the formation of ternary complexes between the PC, a trivalent mannosylated β-cyclodextrin (βCD) conjugate and the macrophage mannose receptor (MMR). First, PC candidates with appropriate relative avidities towards the βCD cavity and the GCase active site were selected to ensure efficient transfer of the PC cargo from the host to the GCase active site. Control experiments confirmed that the βCD carrier was selectively recognized by mannose-specific lectins and that the corresponding PC:mannosylated βCD supramolecular complex retained both the chaperoning activity, as confirmed in human GD fibroblasts, and the MMR binding ability. Finally, fluorescence microscopy techniques proved targeting and cellular uptake of the PC-loaded system in macrophages. Altogether, the results support that combined cyclodextrin encapsulation and glycotargeting may improve the efficacy of PCs for GD. This journal is © 2014 the Partner Organisations. | Descripción: | et al. | URI: | http://hdl.handle.net/10261/99774 | DOI: | 10.1039/c3ob42530d | Identificadores: | doi: 10.1039/c3ob42530d issn: 1477-0520 |
| Aparece en las colecciones: | (IBVF) Artículos (IIQ) Artículos (CABD) Artículos |
Ficheros en este ítem:
| Fichero | Descripción | Tamaño | Formato | |
|---|---|---|---|---|
| accesoRestringido.pdf | 15,38 kB | Adobe PDF |  Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
43
checked on 09-may-2024
WEB OF SCIENCETM
Citations
41
checked on 24-feb-2024
Page view(s)
350
checked on 10-may-2024
Download(s)
136
checked on 10-may-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.